THE SEVERE COMBINED IMMUNODEFICIENT MOUSE (CB-17 SCID) - A NEW MODEL FOR HUMAN SKIN-CANCER INVESTIGATION

被引：0
|
作者：
GOSLEN, JB [1 ]
CHARLEY, MR [1 ]
THARP, MD [1 ]
DENG, JS [1 ]
JEGASOTHY, B [1 ]
机构：
[1] UNIV PITTSBURGH,DEPT DERMATOL,PITTSBURGH,PA 15260
来源：
CLINICAL RESEARCH | 1990年 / 38卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A607 / A607
页数：1
相关论文
共 50 条
  • [41] ROLE OF E-SELECTIN IN AN INVIVO MODEL OF HUMAN INFLAMMATION USING HUMAN SEVERE COMBINED IMMUNODEFICIENCY (SCID) MOUSE CHIMERAS
    YAN, HC
    PILEWSKI, J
    AHERN, T
    LANGERSAFER, P
    ALBELDA, SM
    CLINICAL RESEARCH, 1993, 41 (02): : A352 - A352
  • [42] A comparison of a CB17 scid mouse model and the tetrazolium-dye assay using human haematological tumour cell lines
    Cattan, AR
    Maung, ZT
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 38 (06) : 548 - 552
  • [43] Islet xenograft destruction in the hu-PBL-severe combined immunodeficient (SCID) mouse necessitates anti-CD3 preactivation of human immune cells
    Gysemans, G
    Waer, M
    Laureys, J
    Depovere, J
    Pipeleers, D
    Bouillon, R
    Mathieu, C
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 121 (03): : 557 - 565
  • [44] CB-17 SCID MOUSE STRAIN AS A MODEL FOR HUMAN, DISSEMINATED LEUKEMIA INVIVO - INDUCTION OF DISEASE OF T-CELL AND B-CELL LINEAGE AND USE OF THE SINGLE CYTOTOXIC AGENT, MELPHALAN, AS 1ST-LINE THERAPY
    CATTAN, AR
    DOUGLAS, E
    BRITISH JOURNAL OF HAEMATOLOGY, 1993, 84 : 31 - 31
  • [45] PROPAGATION OF HUMAN PAPILLOMAVIRUS TYPE-11 IN HUMAN XENOGRAFTS USING THE SEVERE COMBINED IMMUNODEFICIENCY (SCID) MOUSE AND COMPARISON TO THE NUDE-MOUSE MODEL
    BONNEZ, W
    ROSE, RC
    DARIN, C
    BORKHUIS, C
    JENSEN, KLD
    REICHMAN, RC
    VIROLOGY, 1993, 197 (01) : 455 - 458
  • [46] The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapse
    Lock, RB
    Liem, N
    Farnsworth, ML
    Milross, CG
    Xue, C
    Tajbakhsh, M
    Haber, M
    Norris, MD
    Marshall, GM
    Rice, AM
    BLOOD, 2002, 99 (11) : 4100 - 4108
  • [47] NEW ANIMAL-MODELS FOR HUMAN AUTOIMMUNE THYROID-DISEASE - XENOGRAFTS OF HUMAN THYROID-TISSUE IN SEVERE COMBINED IMMUNODEFICIENT (SCID) AND NUDE-MICE
    VOLPE, R
    AKASU, F
    MORITA, T
    YOSHIKAWA, N
    RESETKOVA, E
    ARREAZA, G
    MUKUTA, T
    HORMONE AND METABOLIC RESEARCH, 1993, 25 (12) : 623 - 627
  • [48] HIGH HUMAN-IGG LEVELS IN SEVERE COMBINED IMMUNODEFICIENT MOUSE RECONSTITUTED WITH HUMAN SPLENIC TISSUES FROM PATIENTS WITH GASTRIC-CANCER
    KUBOTA, T
    YAMAGUCHI, H
    WATANABE, M
    YAMAMOTO, T
    TAKAHARA, T
    TAKEUCHI, T
    FURUKAWA, T
    KASE, S
    KODAIRA, S
    ISHIBIKI, K
    KITAJIMA, M
    JAPANESE JOURNAL OF CANCER RESEARCH, 1992, 83 (03): : 300 - 303
  • [49] Development and characterization of the ultra-immunodeficient NOD.CB17-Prkdc scid IL2rg tm1 /Bcgen (B-NDG) mouse model
    Naden, Jamie
    Xiang, Jie
    Shen, Yuelei
    Zhang, Meiling
    FASEB JOURNAL, 2020, 34
  • [50] Blocking pleiotrophin activity inhibits multiple myeloma (MM) cell growth in vitro and in a severe combined immunodeficient (SCID)-hu murine model of human MM.
    Campbell, RA
    Chen, HM
    Lee, HJ
    Yeh, HS
    Gordon, MS
    Bonavida, B
    Pang, S
    Said, J
    Berenson, JR
    BLOOD, 2005, 106 (11) : 37A - 37A
12345